OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent Progress on Tubulin Inhibitors with Dual Targeting Capabilities for Cancer Therapy
Shuai Wen, Guan Wang, Yiwen Zhang, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 12, pp. 7963-7990
Closed Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

The interactions of docetaxel with tumor microenvironment
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110214-110214
Closed Access | Times Cited: 40

Silicon switch: Carbon–silicon Bioisosteric replacement as a strategy to modulate the selectivity, physicochemical, and drug‐like properties in anticancer pharmacophores
Jean Fotie, Caitlyn M. Matherne, Jordan E. Wroblewski
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 2, pp. 235-254
Closed Access | Times Cited: 29

Microtubule‐targeting agents for cancer treatment: Seven binding sites and three strategies
Xingyu Wang, Benoı̂t Gigant, Xi Zheng, et al.
MedComm – Oncology (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 27

The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
Antonio Curcio, Roberta Rocca, Stefano Alcaro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 620-620
Open Access | Times Cited: 11

Design, synthesis and biological evaluation of 1,2,3-triazole benzothiazole derivatives as tubulin polymerization inhibitors with potent anti-esophageal cancer activities
Bowen Wu, Wenjing Huang, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116118-116118
Closed Access | Times Cited: 7

First total synthesis, antitumor evaluation and target identification of mornaphthoate E: A new tubulin inhibitor template acting on PI3K/Akt signaling pathway
Peipei Shan, Tao Ye, Ying-De Tang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 5, pp. 2177-2193
Open Access | Times Cited: 7

Discovery of novel dual tubulin and MMPs inhibitors for the treatment of lung cancer and overcoming drug resistance
Guimei Li, Meng Wang, Li Luo, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117249-117249
Closed Access

Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities
Jian Song, Yong-Feng Guan, Wen‐Bo Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114467-114467
Closed Access | Times Cited: 36

Selenium-Containing Agents Acting on Cancer—A New Hope?
Sabrina Garbo, Silvia Di Giacomo, Dorota Łażewska, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 104-104
Open Access | Times Cited: 30

The microtubule cytoskeleton: An old validated target for novel therapeutic drugs
Laurence Lafanéchère
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 28

Recent Advances in Natural Product-Based Hybrids as Anti-Cancer Agents
Eleni Sflakidou, George Leonidis, Eirini Foroglou, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6632-6632
Open Access | Times Cited: 28

A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy
Weixin Zhang, Jiao Huang, Xin-Yi Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115673-115673
Closed Access | Times Cited: 20

Discovery of novel N-benzylarylamide-dithiocarbamate based derivatives as dual inhibitors of tubulin polymerization and LSD1 that inhibit gastric cancers
Xin-Ying Yuan, Chun-Hong Song, Xiujuan Liu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 252, pp. 115281-115281
Closed Access | Times Cited: 17

Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024)
Xingyou Mo, Devendra Pratap Rao, Kirandeep Kaur, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4770-4770
Open Access | Times Cited: 6

Dual-target inhibitors of colchicine binding site for cancer treatment
Lu Lu, Keke Li, Jiaxin Pu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116543-116543
Closed Access | Times Cited: 5

Discovery of novel thienopyridine indole derivatives as inhibitors of tubulin polymerization targeting the colchicine-binding site with potent anticancer activities
Wen‐Bo Liu, Weiguang Yang, Ji Wu, et al.
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117314-117314
Closed Access

Targeting tubulin protein to combat fungal disease: Design, synthesis, and its new mechanistic insights of benzimidazole hydrazone derivatives
Mei Li, Yu Long, Lihui Shao, et al.
International Journal of Biological Macromolecules (2025), pp. 140226-140226
Closed Access

Development of pyrazolo[1,5-a]pyrimidine-grafted coumarins as selective carbonic anhydrase inhibitors and tubulin polymerization inhibitors with potent anticancer activity
Mahmoud S. Elkotamy, Mohamed A. Abdelrahman, Simone Giovannuzzi, et al.
International Journal of Biological Macromolecules (2025), pp. 140462-140462
Closed Access

Antitumor drug eribulin
Yefeng Tang, Tianwen Sun, Hai Shang
Elsevier eBooks (2025), pp. 327-347
Closed Access

Computational framework for minimizing off-target toxicity in capecitabine treatment using natural compounds
Tanya Jamal, Anamta Ali, Shweta Singh Chauhan, et al.
Molecular Diversity (2025)
Closed Access

Aromatic nitroolefin with inhibition efficacy in triple-negative breast cancer cells by dual targeting RXRα and tubulins
Xian‐Jun Qu, Yanxia Wang, Yunqing Xu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117486-117486
Closed Access

Identification of selenium-containing benzamides as potent microtubule-targeting antitumor agents
Bin Jiang, Yijia Zheng, Tiezheng Xue, et al.
Bioorganic Chemistry (2025), pp. 108355-108355
Closed Access

Indazole-based microtubule-targeting agents as potential candidates for anticancer drugs discovery
Dilipkumar Pal, In‐ho Song, Shrikant Dashrath Warkad, et al.
Bioorganic Chemistry (2022) Vol. 122, pp. 105735-105735
Closed Access | Times Cited: 26

An Update on the Recent Advances and Discovery of Novel Tubulin Colchicine Binding Inhibitors
Haoxiang Weng, Jinlong Li, Huajian Zhu, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 73-95
Open Access | Times Cited: 12

Discovery of Novel Isoquinoline Analogues as Dual Tubulin Polymerization/V-ATPase Inhibitors with Immunogenic Cell Death Induction
Jiafu Leng, Yongjun Zhao, Shifang Zhao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 3144-3166
Closed Access | Times Cited: 4

Page 1 - Next Page

Scroll to top